Matthew J. Friedman, MD, PhD

  • 15Articles
  • 101.6KReads
  • 1997–2023Active
  • 22Collaborators
  • 911Citations

About

Matthew J. Friedman, MD, PhD, is affiliated with the Department of Psychiatry at Dartmouth’s Geisel School of Medicine and Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. His publications from 1997 to 2023 focus on posttraumatic stress disorder, veterans and military issues, and addiction. His work includes studies on benzodiazepine prescribing practices, adrenergic mediation of dissociative symptoms, treatment efficacy, and substance use screening in serious mental illness. Frequent collaborators include Brian C. Lund, Nancy C. Bernardy, and Charles R. Marmar.

Publications

PCC
Screening and Referral Algorithm for Substance Use
Original Research

Screening and Referral Algorithm for Substance Use

May 18, 2023

The New Hampshire Hospital Screening and Referral Algorithm, a new data driven substance use screening instrument, holds promise in improving identification of substance use in a seriously mentally ill...
, , , et al
JCP
Deimplementation of Benzodiazepine Prescribing for PTSD Among Veterans
Original Research

Deimplementation of Benzodiazepine Prescribing for PTSD Among Veterans

March 14, 2022

Given concerns about inappropriate prescribing in post-9/11 veterans, a goal of the Veterans Health Administration has been to reduce off-label prescribing practices. This study tracks benzodiazepine prescribing for PTSD...
, ,
JCP
Letter to the Editor

Adrenergic Mediation of Dissociative Symptoms in Posttraumatic Stress Disorder

April 27, 2016

JCP
Commentary

Improving Our Understanding of Posttraumatic Trajectories

September 23, 2015

JCP
Original Research

Prazosin Dosing for PTSD Treatment

May 27, 2015

Read an article examining a cohort of veterans with PTSD initiating prazosin to characterize their typical duration of use and dosing patterns.
, , , et al
JCP
Article

Do Benzodiazepines Reduce the Effectiveness of Exposure Therapy for Posttraumatic Stress Disorder?

December 15, 2013

, , , et al
JCP
Letter to the Editor

Dr Lund and Colleagues Reply

August 15, 2013

, , , et al
JCP
Meta-Analysis

Meta-Analysis of the Efficacy of Treatments for Posttraumatic Stress Disorder

June 15, 2013

, , , et al
JCP
Original Research

Prescribing Trends in Veterans With Posttraumatic Stress Disorder

March 15, 2012

, , , et al
JCP
Original Research

Declining Benzodiazepine Use in Veterans With Posttraumatic Stress Disorder

November 29, 2011

, , , et al
JCP
Letter to the Editor

Reply to "Comments on a Randomized, Double-Blind Comparison of Sertraline and Placebo for Posttraumatic Stress Disorder in a Department of Veterans Affairs Setting

March 18, 2008

, , , et al
JCP
Original Research

Randomized, Double-Blind Comparison of Sertraline and Placebo for Posttraumatic Stress Disorder in a Department of Veterans Affairs Setting

May 15, 2007

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe